← FDA Drug Approvals (Drugs@FDA)

POSACONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WELDING · Approved 2023-06-20

Drug application

FDA Application #

ANDA216326

Application type

Abbreviated New Drug Application (Generic)

Brand name

POSACONAZOLE

Generic name

POSACONAZOLE

Active ingredients

POSACONAZOLE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

WELDING

Manufacturer

Westminster Pharmaceuticals, LLC

First approval

2023-06-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown